Cardiac magnetic resonance imaging to detect and evaluate ischemic heart disease

Hellenic Journal of Cardiology

Volumn 50, Issue 2, 2009, Pages 119-126

  Kirschbaum, Sharon W ^a   Van Geuns, Robert Jan M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Ischemia; Left ventricular function; Magnetic resonance imaging; Viability

Indexed keywords

DOBUTAMINE; GADOLINIUM;

CARDIOGRAPHY; DIAGNOSTIC ACCURACY; ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; NUCLEAR MAGNETIC RESONANCE IMAGING; REVASCULARIZATION; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CARDIAC VOLUME; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL ISCHEMIA; REPRODUCIBILITY OF RESULTS; VENTRICULAR FUNCTION, LEFT;

EID: 65949110357     PISSN: 10117970     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Sourides B, Theofilogiannakos E, Theofilogiannakos G, et al. Clinical experience from 1000 consecutive cardiovascular MRI cases at a tertiary referral medical center. Hellenic J Cardiol. 2007; 48: 192-197. (Pubitemid 47621069)
2. Pamboucas C, Rokas S. Clinical safety of cardiovascular magnetic resonance: cardiovascular devices and contrast agents. Hellenic J Cardiol. 2008; 49: 352-356.
3. Kirschbaum SW, Baks T, Gronenschild EH, et al. Addition of the long-axis information to short-axis contours reduces interstudy variability of left-ventricular analysis in cardiac magnetic resonance studies. Invest Radiol. 2008; 43: 1-6.
4. Danilouchkine MG, Westenberg JJ, de Roos A, Reiber JH, Lelieveldt BP. Operator induced variability in cardiovascular MR: left ventricular measurements and their reproducibility. J Cardiovasc Magn Reson. 2005; 7: 447-457.
5. Meyer GP, Wollert KC, Lotz J, et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation. 2006; 113: 1287-1294.
6. Schachinger V, Assmus B, Britten MB, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol. 2004; 44: 1690-1699.
7. Bellenger NG, Davies LC, Francis JM, Coats AJ, Pennell DJ. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2000; 2: 271-278.
8. Bogaert JG, Bosmans HT, Rademakers FE, et al. Left ventricular quantification with breath-hold MR imaging: comparison with echocardiography. Magma. 1995; 3: 5-12.
9. Grothues F, Smith GC, Moon JC, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002; 90: 29-34. (Pubitemid 34671198)
10. Setser RM, Fischer SE, Lorenz CH. Quantification of left ventricular function with magnetic resonance images acquired in real time. J Magn Reson Imaging. 2000; 12: 430-438.
11. Nagel E, Lehmkuhl HB, Bocksch W, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation. 1999; 99: 763-770.
12. Hundley WG, Hamilton CA, Thomas MS, et al. Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation. 1999; 100: 1697-1702. (Pubitemid 29485251)
13. Nandalur KR, Dwamena BA, Choudhri AF, Nandalur MR, Carlos RC. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol. 2007; 50: 1343-1353. (Pubitemid 47449733)
14. Hundley WG, Morgan TM, Neagle CM, Hamilton CA, Rerk-pattanapipat P, Link KM. Magnetic resonance imaging determination of cardiac prognosis. Circulation. 2002; 106: 2328-2333.
15. Wilke N, Jerosch-Herold M, Wang Y, et al. Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology. 1997; 204: 373-384.
16. Rieber J, Huber A, Erhard I, et al. Cardiac magnetic resonance perfusion imaging for the functional assessment of coronary artery disease: a comparison with coronary angiography and fractional flow reserve. Eur Heart J. 2006; 27: 1465-1471.
17. Costa MA, Shoemaker S, Futamatsu H, et al. Quantitative magnetic resonance perfusion imaging detects anatomic and physiologic coronary artery disease as measured by coronary angiography and fractional flow reserve. J Am Coll Cardiol. 2007; 50: 514-522. (Pubitemid 47126780)
18. Schwitter J, Nanz D, Kneifel S, et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation. 2001; 103: 2230-2235.
19. Schwitter J, Wacker CM, van Rossum AC, et al. MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J. 2008; 29: 480-489.
20. Klem I, Heitner JF, Shah DJ, et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol. 2006; 47: 1630-1638.
21. Paetsch I, Jahnke C, Wahl A, et al. Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation. 2004; 110: 835-842.
22. Specchia G, De Servi S, Scire A, et al. Interaction between exercise training and ejection fraction in predicting prognosis after a first myocardial infarction. Circulation. 1996; 94: 978-982. (Pubitemid 26292850)
23. Wu E, Ortiz JT, Tejedor P, et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart 2007
24. Baer FM, Theissen P, Schneider CA, et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol. 1998; 31: 1040-1048. (Pubitemid 28212504)
25. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999; 100: 1992-2002.
26. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000; 343: 1445-1453.
27. Baks T, van Geuns RJ, Duncker DJ, et al. Prediction of left ventricular function after drug-eluting stent implantation for chronic total coronary occlusions. J Am Coll Cardiol. 2006; 47: 721-725. (Pubitemid 43243092)
28. Wellnhofer E, Olariu A, Klein C, et al. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation. 2004; 109: 2172-2174. (Pubitemid 38625392)
29. Kirschbaum SW, Baks T, van den Ent M, et al. Evaluation of left ventricular function three years after percutaneous recanalization of chronic total coronary occlusions. Am J Cardiol. 2008; 101: 179-185.
30. Baer FM, Smolarz K, Jungehulsing M, et al. Feasibility of high-dose dipyridamole-magnetic resonance imaging for detection of coronary artery disease and comparison with coronary angiography. Am J Cardiol. 1992; 69: 51-56.
31. Jahnke C, Paetsch I, Gebker R, Bornstedt A, Fleck E, Nagel E. Accelerated 4D dobutamine stress MR imaging with k-t BLAST: feasibility and diagnostic performance. Radiology. 2006; 241: 718-728.
32. Paetsch I, Jahnke C, Ferrari VA, et al. Determination of interobserver variability for identifying inducible left ventricular wall motion abnormalities during dobutamine stress magnetic resonance imaging. Eur Heart J. 2006; 27: 1459-1464. (Pubitemid 43998080)
33. Rerkpattanapipat P, Gandhi SK, Darty SN, et al. Feasibility to detect severe coronary artery stenoses with upright treadmill exercise magnetic resonance imaging. Am J Cardiol. 2003; 92: 603-606. (Pubitemid 37013419)
34. Schalla S, Klein C, Paetsch I, et al. Real-time MR image acquisition during high-dose dobutamine hydrochloride stress for detecting left ventricular wall-motion abnormalities in patients with coronary arterial disease. Radiology. 2002; 224: 845-851.
35. Syed MA, Paterson DI, Ingkanisorn WP, et al. Reproducibility and inter-observer variability of dobutamine stress CMR in patients with severe coronary disease: implications for clinical research. J Cardiovasc Magn Reson. 2005; 7: 763-768.
36. Wahl A, Paetsch I, Roethemeyer S, Klein C, Fleck E, Nagel E. High-dose dobutamine-atropine stress cardiovascular MR imaging after coronary revascularization in patients with wall motion abnormalities at rest. Radiology. 2004; 233: 210-216.
37. Doyle M, Fuisz A, Kortright E, et al. The impact of myocardial flow reserve on the detection of coronary artery disease by perfusion imaging methods: an NHLBI WISE study. J Cardiovasc Magn Reson. 2003; 5: 475-485.
38. Ishida N, Sakuma H, Motoyasu M, et al. Noninfarcted myocardium: correlation between dynamic first-pass contrast-enhanced myocardial MR imaging and quantitative coronary angiography. Radiology. 2003; 229: 209-216.
39. Nagel E, Klein C, Paetsch I, et al. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation. 2003; 108: 432-437. (Pubitemid 36935536)
40. Pilz G, Bernhardt P, Klos M, Ali E, Wild M, Hofling B. Clinical implication of adenosine-stress cardiac magnetic resonance imaging as potential gatekeeper prior to invasive examination in patients with AHA/ACC class II indication for coronary angiography. Clin Res Cardiol. 2006; 95: 531-538.
41. Plein S, Radjenovic A, Ridgway JP, et al. Coronary artery disease: myocardial perfusion MR imaging with sensitivity encoding versus conventional angiography. Radiology. 2005; 235: 423-430.
42. Plein S, Greenwood JP, Ridgway JP, Cranny G, Ball SG, Sivananthan MU. Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging. J Am Coll Cardiol. 2004; 44: 2173-2181.
43. Sakuma H, Suzawa N, Ichikawa Y, et al. Diagnostic accuracy of stress first-pass contrast-enhanced myocardial perfusion MRI compared with stress myocardial perfusion scintigraphy. AJR Am J Roentgenol. 2005; 185: 95-102.